Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_assertion description "[Glucagon-like peptide-1(7-36)amide (GLP-1) is an incretin hormone with therapeutic potential for type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_assertion evidence source_evidence_literature NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_assertion SIO_000772 14719796 NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_assertion wasDerivedFrom befree-2016 NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_assertion wasGeneratedBy ECO_0000203 NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.
- befree-2016 importedOn "2016-02-19" NP427868.RAy2nbYEHzybD1d5keq9NquzOLV0XDp4ah76_WT3Zqc9o130_provenance.